Suppr超能文献

受体和活体供体从新冠病毒肺炎康复后的首例肾移植手术。

The first kidney transplantation after recipient and living donor recovered from COVID-19.

作者信息

Kucuk Eyup Veli, Sit Dede, Kayabasi Hasan, Tahra Ahmet, Sobay Resul, Yilmaz Seyma Nur Gunes, Karaoglu Cagla, Ersoy Yesil Ezgi

机构信息

Department of Urology, University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkey.

Department of Nephrology, University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkey.

出版信息

North Clin Istanb. 2021 Feb 17;8(2):187-189. doi: 10.14744/nci.2021.70457. eCollection 2021.

Abstract

SARS-CoV-2 is still a major threat to the world. In this pandemic, transplantation activities have largely been affected worldwide. We are still facing with this pandemic; however, after regulations, we have started our transplantation activities. We report the first kidney transplantation whose recipient and living donor recovered from COVID-19. A 31-year-old male with renal failure was admitted for transplantation with an ABO-compatible relative. The recipient and the donor were tested for COVID-19 before transplantation, and they were both positive with a polymerase chain reaction. The recipient had minor symptoms and received therapy; the living donor also received therapy. Thirty days after recovery, surgery was performed successfully. The recipient was discharged with mycophenolate mofetil (MMF), tacrolimus, and steroid 15 days after surgery. In the follow-up, they were both negative for COVID-19 45 days after surgery. Although there is missing literature regarding safety concerns and short-term follow-up, living-donor transplantation may be considered for patients, who recovered from COVID-19, after careful selection with paying attention to precautions.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)仍然是对世界的重大威胁。在这场大流行中,全球范围内的移植活动受到了很大影响。我们仍面临着这场大流行;然而,在制定相关规定后,我们已开始了移植活动。我们报告了首例受者和活体供者均从新型冠状病毒肺炎(COVID-19)中康复的肾移植病例。一名31岁的肾衰竭男性与一名ABO血型相合的亲属一同入院接受移植手术。移植前对受者和供者进行了COVID-19检测,聚合酶链反应检测结果均为阳性。受者有轻微症状并接受了治疗;活体供者也接受了治疗。康复30天后,成功进行了手术。术后15天,受者服用吗替麦考酚酯(MMF)、他克莫司和类固醇出院。在随访中,术后45天他们的COVID-19检测结果均为阴性。尽管关于安全问题和短期随访的文献较少,但对于从COVID-19中康复的患者,在仔细筛选并注意预防措施后,可考虑进行活体供者移植。

相似文献

1
The first kidney transplantation after recipient and living donor recovered from COVID-19.
North Clin Istanb. 2021 Feb 17;8(2):187-189. doi: 10.14744/nci.2021.70457. eCollection 2021.
3
Living Donor Kidney Transplantation in a Covid-19-Recovered Donor- Recipient Pair: A Case Report.
Indian J Nephrol. 2022 May-Jun;32(3):268-270. doi: 10.4103/ijn.IJN_453_20. Epub 2022 Jan 5.
4
Successful deceased donor kidney transplantation to a recipient with a history of COVID-19 treatment.
J Infect Chemother. 2021 Jul;27(7):1097-1101. doi: 10.1016/j.jiac.2021.03.018. Epub 2021 Mar 29.
5
Renal transplantation during the SARS-CoV-2 pandemic in the UK: Experience from a large-volume center.
Clin Transplant. 2021 Jan;35(1):e14150. doi: 10.1111/ctr.14150. Epub 2020 Nov 23.
8
Liver and Kidney Transplant During a 6-Month Period in the COVID-19 Pandemic: A Single-Center Experience.
Exp Clin Transplant. 2020 Oct;18(5):564-571. doi: 10.6002/ect.2020.0388.
9
Mycophenolate mofetil in pancreas transplantation.
Transplantation. 1998 Aug 15;66(3):318-23. doi: 10.1097/00007890-199808150-00007.

引用本文的文献

1
Utilization of SARS-COV-2 positive donors and recipients for liver transplantation in the pandemic era - An evidence-based review.
J Liver Transpl. 2022 Jul-Sep;7:100081. doi: 10.1016/j.liver.2022.100081. Epub 2022 Mar 11.
2
New Scenarios in Heart Transplantation and Persistency of SARS-CoV-2 (Case Report).
Life (Basel). 2023 Jul 13;13(7):1551. doi: 10.3390/life13071551.
3
Solid organ transplantation from donors with recent or current SARS-CoV-2 infection: A systematic review.
Anaesth Crit Care Pain Med. 2022 Aug;41(4):101098. doi: 10.1016/j.accpm.2022.101098. Epub 2022 May 6.
4
Solid Organ Transplantation in SARS-CoV-2 Recovered Transplant Candidates: a Comprehensive Review of Recent Literature.
Curr Transplant Rep. 2022;9(2):95-107. doi: 10.1007/s40472-022-00362-5. Epub 2022 Mar 9.
5
Solid Organ Transplantation From SARS-CoV-2-infected Donors to Uninfected Recipients: A Single-center Experience.
Transplant Direct. 2022 Jan 13;8(2):e1286. doi: 10.1097/TXD.0000000000001286. eCollection 2022 Feb.
6
Use of Organs from SARS-CoV-2 Infected Donors: Is It Safe? A Contemporary Review.
Curr Transplant Rep. 2021;8(4):281-292. doi: 10.1007/s40472-021-00343-0. Epub 2021 Oct 26.

本文引用的文献

2
COVID-19 and Living Donor Kidney Transplantation in Naples during the Pandemic.
Biomed Res Int. 2020 Oct 15;2020:5703963. doi: 10.1155/2020/5703963. eCollection 2020.
3
COVID-19 outcomes in patients waitlisted for kidney transplantation and kidney transplant recipients.
Am J Transplant. 2021 Apr;21(4):1576-1585. doi: 10.1111/ajt.16351. Epub 2020 Nov 8.
4
Successful liver transplantation in a patient recovered from COVID-19.
Transpl Infect Dis. 2021 Apr;23(2):e13492. doi: 10.1111/tid.13492. Epub 2020 Oct 22.
7
COVID-19 in recent kidney transplant recipients.
Am J Transplant. 2020 Nov;20(11):3206-3209. doi: 10.1111/ajt.16120. Epub 2020 Jun 28.
8
Organ procurement and transplantation during the COVID-19 pandemic.
Lancet. 2020 May 23;395(10237):e95-e96. doi: 10.1016/S0140-6736(20)31040-0. Epub 2020 May 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验